Evidence map›Paper›PMID 31608217›Full record

ArticleJournal of clinical and translational hepatology2019

A Potential Functional Cure in Chinese HBeAg-negative Chronic Hepatitis B Patients Treated with Peg-interferon Alpha-2a.

Xinyue Chen, Qianguo Mao, Yao Xie, Xiaoguang Dou, Qing Xie, Jifang Sheng, Zhiliang Gao, Xiaoling Zhou, Yingxia Liu, Huanwei Zheng and 10 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical and translational hepatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Observational
  3. B Cell-mediated Humoral Immunity in Chronic Hepatitis B Infection.Journal of clinical and translational hepatology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 8 institutions in 1 country.

Xinyue ChenInternational Medicine Ward, Beijing YouAn Hospital, Capital Medical University, Beijing, China.
Qianguo MaoDepartment of Infectious Diseases, Xiamen Hospital of Traditional Chinese Medicine, Xiamen, Fujian, China.
Yao XieDepartment of Liver Disease, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Xiaoguang DouDepartment of Infectious Diseases, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
Qing XieDepartment of Infectious Diseases, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Jifang ShengDepartment of Infectious Diseases, The First Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang, China.
Zhiliang GaoDepartment of Infectious Diseases, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Xiaoling ZhouDepartment of Gastroenterology, Liuzhou Traditional Chinese Medical Hospital, Liuzhou, Guangxi, China.
Yingxia LiuDepartment of Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen, Guangdong, China.
Huanwei ZhengDepartment of Infectious Diseases, The Fifth Hospital of Shijiazhuang, Shijiazhuang, Hebei, China.
Shuqin ZhangDepartment of Infectious Diseases, Hepatology Hospital of Jilin Province, Changchun, Jilin, China.
Shibo LiDepartment of Infectious Diseases, Zhoushan Hospital of Zhejiang Province, Zhoushan, Zhejiang, China.
Fusheng ZhuDepartment of Infectious Diseases, General Hospital of Dagang Oilfield, Tianjin, China.
Yuqin XuDepartment of Infectious Diseases, The 211 Hospital of People's Liberation Army, Harbin, Heilongjiang, China.
Mingxiang ZhangDepartment of Integrated Traditional and Western Medicine on Liver Diseases, The Sixth People's Hospital of Shenyang, Shenyang, Liaoning, China.
Yaoren HuDepartment of Liver Disease, Ningbo No. 2 Hospital of Zhejiang Province, Ningbo, Zhejiang, China.
Xiaoping ChenDepartment of Infectious Diseases, Guangdong General Hospital, Guangzhou, Guangdong, China.
Yan HuangDepartment of Medical Science, Shanghai Roche Pharmaceuticals Ltd., Shanghai, China.
Hong RenDepartment of Infectious Diseases, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Jidong JiaDepartment of Liver Disease, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Capital Medical University · CNChina Medical University · CNChongqing Medical University · CNRoche (China) · CNRuijin Hospital · CNShenzhen Third People’s Hospital · CNSun Yat-sen University · CNUnion Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Chronic hepatitis BInterferon alphaObservational studyProspective studies

Identifiers

PMID31608217
PMCPMC6783682
OpenAlexW2969389433

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.